Submission of Matters to a Vote of Security Holders

Business Context and Reporting Period

This Form 8-K reports the results of the annual meeting of stockholders for Ekso Bionics Holdings, Inc. held on June 20, 2017. The filing details the voting outcomes for four proposals submitted to security holders. Note: The request metadata references "Chronoscale Holdings Corp," but the filing text explicitly identifies the registrant as Ekso Bionics Holdings, Inc.

Key Financial Metrics

This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.

Material Changes and Voting Results

The filing summarizes the following voting outcomes at the Annual Meeting:

  • Proposal 1 (Election of Directors): All eight nominees were elected. Broker non-votes totaled 10,376,874 shares for each nominee.
  • Proposal 2 (2017 Employee Stock Purchase Plan): Approved with 6,104,867 votes "For" versus 419,302 "Against."
  • Proposal 3 (Equity Incentive Plan Amendment): Approved to increase available shares from 3,714,285 to 4,714,285. Received 5,015,192 votes "For" versus 1,593,942 "Against."
  • Proposal 4 (Ratification of Auditors): OUM & Co., LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2017. Received 16,419,641 votes "For" versus 389,483 "Against."

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of shareholder voting results.

Investor Verification Checklist

  • Verify the correct registrant name is Ekso Bionics Holdings, Inc., not Chronoscale Holdings Corp.
  • Confirm the successful ratification of OUM & Co., LLP as the independent auditor for the 2017 fiscal year.
  • Note the significant number of broker non-votes (10,376,874) on the director election and equity plan proposals.
  • Review the approved increase in the equity incentive plan share pool to 4,714,285 shares for potential dilution impact.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.